These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11769390)

  • 21. New treatment strategies in idiopathic nephrotic syndrome.
    Ulinski T; Aoun B
    Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
    Moudgil A; Bagga A; Jordan SC
    Pediatr Nephrol; 2005 Oct; 20(10):1376-81. PubMed ID: 15977023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine in glomerular disease.
    Mowry JA; McCarthy ET
    Semin Nephrol; 1996 Nov; 16(6):548-54. PubMed ID: 9125799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
    Wang W; Xia Y; Mao J; Chen Y; Wang D; Shen H; Fu H; Du L; Liu A
    Pediatr Nephrol; 2012 Nov; 27(11):2073-2079. PubMed ID: 22714672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T; Dubourg L; Saïd MH; Parchoux B; Ranchin B; Cochat P
    Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
    Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials].
    Chen LZ; Jiang XY; Lu HY; Zhang QL; Mo Y
    Zhonghua Er Ke Za Zhi; 2009 Dec; 47(12):898-903. PubMed ID: 20193140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mycophenolate mofetil and cyclosporine in the treatment of steroid-dependent nephrotic syndrome with frequent relapses].
    Márquez Peiró JF; Porta Oltra B; Marín Serra J
    An Pediatr (Barc); 2008 Sep; 69(3):258-62. PubMed ID: 18775272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.
    Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW
    Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Other immunosuppressive agents for focal segmental glomerulosclerosis.
    Ponticelli C; Passerini P
    Semin Nephrol; 2003 Mar; 23(2):242-8. PubMed ID: 12704585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A
    J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
    Gellermann J; Querfeld U
    Pediatr Nephrol; 2004 Jan; 19(1):101-4. PubMed ID: 14753204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
    Xia ZK; Liu GL; Gao YF; Fu J; Fu YF; Zhang LF; Fan ZM
    Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
    El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Sheashaa H; Sabry A; Hassan N; Sayed-Ahmad N; Sobh M
    Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
    Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.